Navigation Links
NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
Date:6/11/2013

HOUSTON, June 11, 2013 /PRNewswire-USNewswire/ -- The NSBRI Industry Forum today announced a new funding opportunity for small U.S. companies with biomedical products that hold promise for use in space.

(Logo: http://photos.prnewswire.com/prnh/20130611/DC29942LOGO)

The NSBRI Industry Forum has initiated a new grant funding program for small, U.S.-based companies who are in, or have graduated from, business accelerators.  NSBRI is partnering with prominent business accelerators in the biotechnology, health and health-IT sectors to identify the best and brightest candidates for the program, which seeks innovative solutions to the health care challenges inherent to spaceflight. Companies, in partnership with sponsoring accelerators, can submit applications for the SMARTCAP-Accel program from June 11, 2013 through July 22, 2013, online at www.smartcap.org.

Launched today at a joint media event with the Office of Economic Growth and Innovation of the City of Louisville, Kentucky, and its new accelerator XLerateHealth, the SMARTCAP-Accel program marks an expansion of NSBRI's already highly successful SMARTCAP program. Like the original program, SMARTCAP-Accel will offer small U.S. companies the opportunity to receive non-dilutive project funding and collaboration opportunities with NSBRI and its research partners.

Project budgets ranging from $10,000 to $200,000 will be considered, but to maximize program funds all SMARTCAP-Accel grants must be matched with new investments from another funding source.

Dr. Dorit Donoviel, NSBRI's Industry Forum Lead, believes that this program, a partnership between government, academia and industry, will advance products in a more cost-efficient and timely manner. "Administering healthcare in space requires innovative medical solutions that may stall in the laboratory due to insufficient funding and a clear path to overcome regulatory hurdles," Donoviel explains. "The resources required to move a novel technology from 'bench to bedside' for space and Earth are significant and require expertise in science, medicine, engineering, and business," she added. "For all these reasons, it is critical that government, universities, and the private sector partner to develop promising technologies that meet a medical need for spaceflight and for Earth and that's what we are doing with SMARTCAP-Accel."

According to Dr. Ted Smith, Chief of Economic Growth and Innovation for the City of Louisville and a member of the NSBRI Industry Forum Steering Council, the program helps open up new thinking in a way that will benefit tax-payers. "The SMARTCAP program harnesses the creative energy in innovators and entrepreneurs out there that would never respond to a life sciences procurement opportunity," remarked Smith. "Essentially, the SMARTCAP and SMARTCAP-Accel programs are crowd-sourced problem solving, and that is probably the most tax-efficient thing we can do to generate effective, innovative solutions." He added, "Accelerators have become a major pathway for entrepreneurs to obtain capital and mentorship. These accelerators see hundreds of applications each cycle, and vet the opportunities - and NSBRI benefits from that pipeline of entrepreneurial refinement."

Successful SMARTCAP-Accel applications will be aimed at developing products that can better safeguard the health of humans working in space, as well as fulfill unmet medical needs on Earth.

The constraints on health care in space are similar to those experienced in remote or under-resourced regions on Earth. Technology solutions must be largely non-invasive, user-friendly for non-expert operators, compact, lightweight, and consume minimal power, water or other resources.  IT solutions must stand alone and not require internet connectivity.

"For these reasons, we have seen time and time again that products developed for space possess unique features that lead to commercial advantages on Earth," Dr. Donoviel explained.

The human health risks or medical care challenges related to space travel are wide ranging.  They include:

  • Exposure to ionizing radiation;
  • Muscle and bone loss, due to microgravity;
  • Intracranial hypertension and related visual impairment;
  • Renal stone formation;
  • Sleep loss and circadian disruption;
  • Psychiatric/behavioral issues associated with isolation and confinement;
  • Routine health surveillance;
  • Emergency/critical care; and
  • Clinical decision support for autonomous care

For a more complete list of risks associated with human space flight see www.nsbri.org and http://humanresearchroadmap.nasa.gov/

Eligibility

Accelerators: U.S. based accelerators that have directly funded companies within the past 12 months may nominate up to two applicants that have already been selected for support by the accelerator.

Nominees:  Nominated companies must either be currently receiving support from the accelerator or must have successfully exited the accelerator.  To be considered, companies must be based in the U.S., have 500 or fewer employees, and be one of up to two companies sponsored by a qualifying accelerator.

Projects: A proposed project should meet at least one key milestone along the path to product commercialization.  Examples of desirable projects include:

  • Proof of concept studies;
  • Refinement of prototypes;
  • Re-formulation;
  • Safety;
  • Regulatory; and
  • Usability testing

NSBRI will work with successful candidates to develop a work plan that is aligned with both the terrestrial and space applications of the product.

About NSBRI
The National Space Biomedical Research Institute, NSBRI, is a 501(c)3 organization funded by NASA. Its mission is to lead a national program to mitigate the health risks related to long-duration spaceflight and to apply the discoveries to improve life on Earth. Annually, the Institute's science, technology and education projects take place at approximately 60 institutions and companies across the United States.

About NSBRI Industry Forum
The NSBRI Industry Forum was established to accelerate the development and commercialization of products to enhance health in space and on Earth.  

About the Office of Economic Growth and Innovation of the City of Louisville, Kentucky
The Office of Economic Growth and Innovation fosters a robust business climate, by promoting job creation, helping business navigate potential financing, meeting workforce needs, creating amenities within our region, and balancing growth by enhancing the environment, in order to improve the quality of life in Louisville Metro.


'/>"/>
SOURCE National Space Biomedical Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. NSBRI Funds Cerebrotech to Accelerate Development of Brain Monitoring Device
2. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
3. Metabolix Executives to Present at Leading Industry Conferences
4. Global Catalysts Industry 2013-2018: Trend, Profit, and Forecast Analysis - Benchmark the Worlds Top 5 Drug Companies
5. Heptares to Present at Upcoming Biotech Industry Conferences
6. Adult Acne Treatment Explains a New Upcoming Study that may Change the Acne Treatment Industry
7. Leveraging an Academic-Industry Partnership for Commercial Success, New Life Science Webinar Hosted By Xtalks
8. United Airlines and AltAir Fuels to Bring Commercial-Scale, Cost-Competitive Biofuels to Aviation Industry
9. Lucintel Estimates Global Agro-Food Products Industry to Reach $1,148.3 Billion By 2018
10. Lucintel Report Outlines $821.8 Billion Market for Global Basic Petrochemicals Industry by 2018
11. Lucintel Analyzes EMC in Global Semiconductor Packaging Industry: Market Expected to Reach $1,702 Million in 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
Breaking Biology Technology:
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
Breaking Biology News(10 mins):